ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

MXC Mgc Pharmaceuticals Limited

22.00
0.00 (0.00%)
20 Jan 2025 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Mgc Pharmaceuticals Limited LSE:MXC London Ordinary Share AU000000MXC6 ORD NPV (DI)
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 22.00 - 0.00 00:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Drug & Proprietary Stores 3.02M -17.53M -0.3998 -0.48 9.65M
Mgc Pharmaceuticals Limited is listed in the Drug & Proprietary Stores sector of the London Stock Exchange with ticker MXC. The last closing price for Mgc Pharmaceuticals was 22p. Over the last year, Mgc Pharmaceuticals shares have traded in a share price range of 17.50p to 24.50p.

Mgc Pharmaceuticals currently has 43,851,631 shares in issue. The market capitalisation of Mgc Pharmaceuticals is £9.65 million. Mgc Pharmaceuticals has a price to earnings ratio (PE ratio) of -0.48.

Mgc Pharmaceuticals Share Discussion Threads

Showing 15776 to 15795 of 17575 messages
Chat Pages: Latest  643  642  641  640  639  638  637  636  635  634  633  632  Older
DateSubjectAuthorDiscuss
22/4/2022
13:11
You'd think so, wouldn't you?
sloppyjoe2
22/4/2022
08:58
A patent on a product no one wants delivered before the next dilution..... well done Roby
beltd
21/4/2022
08:55
Too much good news to keep this below 2p
kirk 6
21/4/2022
08:17
Hopefully we've seen the bottom here and this will now start to move back up...
sloppyjoe2
21/4/2022
07:37
Good RNS, paving way for factory GMP approval coming soon all being well
jonah292
21/4/2022
06:48
Excellent news
kirk 6
20/4/2022
07:51
Turner Pope is this a Russian company ? I'm betting you lot have made good money out of this shambles !
amaretto1
19/4/2022
16:28
Placing is DUE.

Suspect this time, Convertible notes are coming. AMEN

silly billy
19/4/2022
16:26
This pile of dung goes to 0.1p. Poor FLC, claiming share looking very cheap. SAD, VERY SAD.

Our top latrine cleaner business owner is sinking down in this cesspit. Mind you, the bankrupt chap, pour money in EUA 40p, bought POG at 5p after it rose from 1.2p and bought POLY at 400p.

But we all know the chap bought this gem here, fantasising 150p, GWP mcap of 7bn. LOL

The chap should stop downing white lightning.

These little maggots should keep their giros under the mattress.

The shorting crew will not stop.


FLC the superhero SAS, SBS, DELTA FORCE, SUPERMAN, BATMAN has taken out 15 thousand Ruskies. Donate to him.

silly billy
19/4/2022
16:12
Q1 trading update should be out next week and will hopefully have some numbers in it to support the bullish revenue talk. Shares looking very cheap again.
flc
14/4/2022
12:45
Guessing that's why the price is collapsing then... good news travels fast, bad news often delayed... along with the trials now lol
jason_scrap
14/4/2022
12:25
jonah it's start date isn't till June 2022 this year so finish June 2023. I don't think that is different to what has been shared via RNS before is it??
heatseek77
13/4/2022
09:47
Any thoughts on the below Cannepil trial which has recently been updated to state won't be completed until June 2023? This means will be a year behind. What do you think this means to short term cash flow if no trials are going to be completed this year?
jonah292
12/4/2022
11:42
Heat I'm still long here and have added though I think it will be quite sometime yet. On a personal note Fingers crossed for DFC, Accrington safe and Tavistock to get promotion.
ant15
11/4/2022
13:12
MGC tweeted today -
As a BioPharma company with cannabis-based medicines, we go through the most rigorous testing. We are pleased to see that the authorities in the UK are evaluating the safety of all CBD products available in the UK.

✍️ @McCuskeris for @BusinessCann

looneytune
10/4/2022
20:03
htTps://metro.co.uk/2022/04/07/nhs-could-prescribe-cannabis-as-painkiller-as-hundreds-join-trial-16427192/Seems kinda relevant
a_2_b
10/4/2022
16:57
Agree the green light for MGC so we should hopefully get back over 2p this week
kirk 6
10/4/2022
11:08
Yes i think this is significant news that will be a major boost to MGC.
pillow
09/4/2022
12:22
Good job that the RNS this week means MGC treatments are classed as medicines now not cannabis products if sold via Scientus. CBD regulations for retail products has been in situ for a couple of years by FSA they are just not enforced/regulated yet. Basically means no proof whether they actually work so understandable why this would be needed in the long run to ensure safety etc
jonah292
09/4/2022
09:49
Could be classed as very good news for MGC
kirk 6
Chat Pages: Latest  643  642  641  640  639  638  637  636  635  634  633  632  Older

Your Recent History

Delayed Upgrade Clock